Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.16 $1.58 Million - $3.13 Million
607,297 Added 17.96%
3,988,967 $27 Million
Q2 2022

Aug 15, 2022

BUY
$2.46 - $5.2 $1.83 Million - $3.86 Million
743,208 Added 28.17%
3,381,670 $15.9 Million
Q1 2022

May 13, 2022

BUY
$4.16 - $9.08 $582,483 - $1.27 Million
140,020 Added 5.6%
2,638,462 $12.5 Million
Q4 2021

Feb 14, 2022

SELL
$7.65 - $11.38 $553,385 - $823,206
-72,338 Reduced 2.81%
2,498,442 $21.2 Million
Q2 2021

Aug 16, 2021

BUY
$11.87 - $15.96 $725,233 - $975,124
61,098 Added 2.43%
2,570,780 $32.3 Million
Q1 2021

May 13, 2021

BUY
$13.87 - $21.04 $2.64 Million - $4 Million
190,200 Added 8.2%
2,509,682 $34.8 Million
Q4 2020

Feb 12, 2021

BUY
$17.03 - $22.45 $2.97 Million - $3.91 Million
174,279 Added 8.12%
2,319,482 $46 Million
Q3 2020

Nov 12, 2020

BUY
$19.3 - $26.92 $29.9 Million - $41.6 Million
1,546,990 Added 258.6%
2,145,203 $49.1 Million
Q2 2020

Aug 13, 2020

BUY
$22.0 - $22.5 $13.2 Million - $13.5 Million
598,213 New
598,213 $13.5 Million

About Akouos, Inc.


  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.